News
BridgeBio grabs FDA approval for its ATTR cardiomyopathy drug Attruby, setting up a challenge to market leader Pfizer. Skip to main content Friday 20 June 2025 . BlueSky linkedin youtube rss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback